BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 22985928)

  • 1. Evaluation of in vitro and in vivo inhibitory effects of fusidic acid on Babesia and Theileria parasites.
    Salama AA; Aboulaila M; Moussa AA; Nayel MA; El-Sify A; Terkawi MA; Hassan HY; Yokoyama N; Igarashi I
    Vet Parasitol; 2013 Jan; 191(1-2):1-10. PubMed ID: 22985928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phytochemical Screening and Antiprotozoal Effects of the Methanolic
    Batiha GE; Magdy Beshbishy A; Adeyemi OS; Nadwa EH; Rashwan EKM; Alkazmi LM; Elkelish AA; Igarashi I
    Molecules; 2020 Jan; 25(3):. PubMed ID: 32012795
    [No Abstract]   [Full Text] [Related]  

  • 3. Phytochemical Characterization and Chemotherapeutic Potential of
    Batiha GE; Beshbishy AM; Guswanto A; Nugraha A; Munkhjargal T; M Abdel-Daim M; Mosqueda J; Igarashi I
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32102270
    [No Abstract]   [Full Text] [Related]  

  • 4. Babesia duncani, A Model Organism for Investigating Intraerythrocytic Parasitism and Novel Anti-Parasitic Therapeutic Strategies.
    Fang T; Ben Mamoun C
    J Infect Dis; 2024 Apr; ():. PubMed ID: 38626187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiparasitic activity of FLLL-32 against four
    El-Sayed SAE; El-Alfy ES; Baghdadi HB; Sayed-Ahmed MZ; Alqahtani SS; Alam N; Ahmad S; Ali MS; Igarashi I; Rizk MA
    Front Pharmacol; 2023; 14():1278451. PubMed ID: 38027032
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of methanolic extract from
    Rizk MA; El-Salam El-Sayed SA; Al-Araby M; Igarashi I
    Vet World; 2022 Jan; 15(1):76-82. PubMed ID: 35369597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioactivities and Structure-Activity Relationships of Fusidic Acid Derivatives: A Review.
    Long J; Ji W; Zhang D; Zhu Y; Bi Y
    Front Pharmacol; 2021; 12():759220. PubMed ID: 34721042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human Babesiosis in Europe.
    Hildebrandt A; Zintl A; Montero E; Hunfeld KP; Gray J
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Human Babesiosis: Then and Now.
    Renard I; Ben Mamoun C
    Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twenty Years of Equine Piroplasmosis Research: Global Distribution, Molecular Diagnosis, and Phylogeny.
    Tirosh-Levy S; Gottlieb Y; Fry LM; Knowles DP; Steinman A
    Pathogens; 2020 Nov; 9(11):. PubMed ID: 33171698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of burn wound healing activity of novel fusidic acid loaded microemulsion based gel in male Wistar albino rats.
    Okur ME; Ayla Ş; Yozgatlı V; Aksu NB; Yoltaş A; Orak D; Sipahi H; Üstündağ Okur N
    Saudi Pharm J; 2020 Mar; 28(3):338-348. PubMed ID: 32194336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myrrh Oil
    AbouLaila M; El-Sayed SAE; Omar MA; Al-Aboody MS; Aziz ARA; Abdel-Daim MM; Rizk MA; Igarashi I
    Pathogens; 2020 Feb; 9(3):. PubMed ID: 32121352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Effects of Atranorin towards the Proliferation of
    Beshbishy AM; Batiha GE; Alkazmi L; Nadwa E; Rashwan E; Abdeen A; Yokoyama N; Igarashi I
    Pathogens; 2020 Feb; 9(2):. PubMed ID: 32079149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and efficacy of hydroxyurea and eflornithine against most blood parasites Babesia and Theileria.
    El-Saber Batiha G; Magdy Beshbishy A; Stephen Adeyemi O; Nadwa E; Rashwan E; Yokoyama N; Igarashi I
    PLoS One; 2020; 15(2):e0228996. PubMed ID: 32053698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro and in vivo inhibitory effect of thymoquinone on piroplasm parasites.
    El-Sayed SAE; Rizk MA; Yokoyama N; Igarashi I
    Parasit Vectors; 2019 Jan; 12(1):37. PubMed ID: 30651142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond.
    Van Voorhis WC; Adams JH; Adelfio R; Ahyong V; Akabas MH; Alano P; Alday A; Alemán Resto Y; Alsibaee A; Alzualde A; Andrews KT; Avery SV; Avery VM; Ayong L; Baker M; Baker S; Ben Mamoun C; Bhatia S; Bickle Q; Bounaadja L; Bowling T; Bosch J; Boucher LE; Boyom FF; Brea J; Brennan M; Burton A; Caffrey CR; Camarda G; Carrasquilla M; Carter D; Belen Cassera M; Chih-Chien Cheng K; Chindaudomsate W; Chubb A; Colon BL; Colón-López DD; Corbett Y; Crowther GJ; Cowan N; D'Alessandro S; Le Dang N; Delves M; DeRisi JL; Du AY; Duffy S; Abd El-Salam El-Sayed S; Ferdig MT; Fernández Robledo JA; Fidock DA; Florent I; Fokou PV; Galstian A; Gamo FJ; Gokool S; Gold B; Golub T; Goldgof GM; Guha R; Guiguemde WA; Gural N; Guy RK; Hansen MA; Hanson KK; Hemphill A; Hooft van Huijsduijnen R; Horii T; Horrocks P; Hughes TB; Huston C; Igarashi I; Ingram-Sieber K; Itoe MA; Jadhav A; Naranuntarat Jensen A; Jensen LT; Jiang RH; Kaiser A; Keiser J; Ketas T; Kicka S; Kim S; Kirk K; Kumar VP; Kyle DE; Lafuente MJ; Landfear S; Lee N; Lee S; Lehane AM; Li F; Little D; Liu L; Llinás M; Loza MI; Lubar A; Lucantoni L; Lucet I; Maes L; Mancama D; Mansour NR; March S; McGowan S; Medina Vera I; Meister S; Mercer L; Mestres J; Mfopa AN; Misra RN; Moon S; Moore JP; Morais Rodrigues da Costa F; Müller J; Muriana A; Nakazawa Hewitt S; Nare B; Nathan C; Narraidoo N; Nawaratna S; Ojo KK; Ortiz D; Panic G; Papadatos G; Parapini S; Patra K; Pham N; Prats S; Plouffe DM; Poulsen SA; Pradhan A; Quevedo C; Quinn RJ; Rice CA; Abdo Rizk M; Ruecker A; St Onge R; Salgado Ferreira R; Samra J; Robinett NG; Schlecht U; Schmitt M; Silva Villela F; Silvestrini F; Sinden R; Smith DA; Soldati T; Spitzmüller A; Stamm SM; Sullivan DJ; Sullivan W; Suresh S; Suzuki BM; Suzuki Y; Swamidass SJ; Taramelli D; Tchokouaha LR; Theron A; Thomas D; Tonissen KF; Townson S; Tripathi AK; Trofimov V; Udenze KO; Ullah I; Vallieres C; Vigil E; Vinetz JM; Voong Vinh P; Vu H; Watanabe NA; Weatherby K; White PM; Wilks AF; Winzeler EA; Wojcik E; Wree M; Wu W; Yokoyama N; Zollo PH; Abla N; Blasco B; Burrows J; Laleu B; Leroy D; Spangenberg T; Wells T; Willis PA
    PLoS Pathog; 2016 Jul; 12(7):e1005763. PubMed ID: 27467575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bumped kinase inhibitor prohibits egression in Babesia bovis.
    Pedroni MJ; Vidadala RS; Choi R; Keyloun KR; Reid MC; Murphy RC; Barrett LK; Van Voorhis WC; Maly DJ; Ojo KK; Lau AO
    Vet Parasitol; 2016 Jan; 215():22-8. PubMed ID: 26790733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization of a Fluorescence-Based Assay for Large-Scale Drug Screening against Babesia and Theileria Parasites.
    Rizk MA; El-Sayed SA; Terkawi MA; Youssef MA; El Said el Sel S; Elsayed G; El-Khodery S; El-Ashker M; Elsify A; Omar M; Salama A; Yokoyama N; Igarashi I
    PLoS One; 2015; 10(4):e0125276. PubMed ID: 25915529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Theileria equi isolates vary in susceptibility to imidocarb dipropionate but demonstrate uniform in vitro susceptibility to a bumped kinase inhibitor.
    Hines SA; Ramsay JD; Kappmeyer LS; Lau AO; Ojo KK; Van Voorhis WC; Knowles DP; Mealey RH
    Parasit Vectors; 2015 Jan; 8():33. PubMed ID: 25600252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Babesia bovis dihydroorotate dehydrogenase (BboDHODH) is a novel molecular target of drug for bovine babesiosis.
    Kamyingkird K; Cao S; Masatani T; Moumouni PF; Vudriko P; Mousa AA; Terkawi MA; Nishikawa Y; Igarashi I; Xuan X
    J Vet Med Sci; 2014 Mar; 76(3):323-30. PubMed ID: 24189582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.